Quantcast

Startup will develop UMB disease-detection technology

The University of Maryland, Baltimore has spawned a new startup that will use genome research to target inflammatory bowel ailments such as Crohn's disease. Technology developed by two doctors from the Institute for Genome Sciences at the university's medical school looks at the genomes of bacteria in the human gut to detect diseases such as ulcerative colitis and Crohn's.

Leave a Reply

Your email address will not be published. Required fields are marked *

*